Medications for Dementia: An Update
The Carlat Psychiatry Report, Volume 5, Number 5, May 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n5/
Issue Links: Learning Objectives | Editorial Information
Topics: Dementia
Daniel Carlat, MD
It has now been a full ten years since the first of the second-generation cholinesterase inhibitors (CIs), Aricept (donepezil) was approved for Alzheimer’s dementia.
You can't view details of this content, please login or buy subscription here
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.